Key pharma stocks, including Granules India and Gland Pharma, have shown substantial recovery, with the Nifty Pharma index ...

Chief Minister A. Revanth Reddy will release Bandaru Dattatreya’s autobiography, Pajala Kathe Naa Atmakatha, at Shilpakala ...

Dr. Reddy's Laboratories Ltd has generally positive cash flows and an excellent current ratio of 2.58. Additionally, the ...

Mayur Maheshwari, CEO of UPSIDA, said the Bulk Drug Pharma Park would be important in reducing India's dependence on China ...

Dr. Reddy's Labs ADR saw both earnings and sales growth rise last quarter. Earnings-per-share increased from 0% to 16%.

Dr. Crystal Truong and Dr. Vish Reddy opened the doors to Apex Eye in Frisco with a clear mission to create an ophthalmology ...

Ontario, Calif.-based Prime Healthcare realigned services at Illinois hospitals it recently acquired from St. Louis-based Ascension, citing unsustainable financial losses and low patient volumes that ...

Dr. Reddy's Laboratories Ltd. closed 7.02% short of its 52-week high of 1,420.20 rupees, which the company achieved on August ...

Dr. Reddy’s Laboratories has partnered with global biotech firm Alvotech to co-develop and commercialize a biosimilar of ...

Dr. Reddy's Laboratories Ltd marked a 5.4% change today, compared to -0.0% for the S&P 500. Is it a good value at today's ...

Alvotech and Dr. Reddy's will co-develop a biosimilar to Keytruda, aiming to expand global access to cancer treatment alternatives.

Dr. Reddy's Laboratories Ltd. Sponsored ADR (RDY) is currently at $15.62, up $0.88 or 5.93% --Would be highest close since Jan. 8, 2025, when it closed at $15.81 --On pace for largest percent increase ...